Back to Search
DAVID BRADLEY, O.D.
O.D.
Optometrist
NPI: 1275504391IndividualAccepts Medicare
Specialties, Licenses & Credentials
OptometristPrimary
Optometrist
Code: 152W00000X
7747T(CA)
CMS Specialties
PrimaryOPTOMETRY
Education
SOUTHERN CALIFORNIA COLLEGE OF OPTOMETRY
Class of 1983
Clinical Trials (2)
2
Linked Trials
0
Recruiting
1
With Results
Research & Publications (12)
Alterations in energy balance following exenatide administration.
PMID 22735035·Appl Physiol Nutr Metab·2012
3-trial
Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial.
PMID 20876408·Arch Intern Med·2010
4-observational
Prediabetes: the importance of early identification and intervention.
PMID 20675976·Postgrad Med·2010
6-review
Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatin.
PMID 20413733·Arterioscler Thromb Vasc Biol·2010
3-trial
Relationship between beta-cell mass and diabetes onset.
PMID 18834430·Diabetes Obes Metab·2008
7-preclinical
Weight loss therapy improves pancreatic endocrine function in obese older adults.
PMID 18388888·Obesity (Silver Spring)·2008
2-rct
Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment.
PMID 18332269·Circulation·2008
8-other
Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on beta-cell function in normal living conditions.
PMID 17468345·Diabetes Care·2007
2-rct
Haplotypes in the lipoprotein lipase gene influence high-density lipoprotein cholesterol response to statin therapy and progression of atherosclerosis in coronary artery bypass grafts.
PMID 16755277·Pharmacogenomics J·2007
8-other
One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes.
PMID 15111485·Diabetes·2004
3-trial
Accurate assessment of beta-cell function: the hyperbolic correction.
PMID 11815482·Diabetes·2002
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1160 LIVE OAK BLVD
YUBA CITY, CA 95991 - Phone
- (530) 673-8440
Quick Facts
- NPI
- 1275504391
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 43
- Clinical Trials
- 2
- Publications
- 12
Are you this provider?
Claim Your Profile